Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

3.18
-0.2700-7.83%
Post-market: 3.250.0700+2.20%19:35 EDT
Volume:1.75M
Turnover:5.70M
Market Cap:270.11M
PE:-2.70
High:3.50
Open:3.49
Low:3.16
Close:3.45
Loading ...

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Motley Fool
·
09 Mar

William Blair Initiates a Hold Rating on Terns Pharmaceuticals (TERN)

TIPRANKS
·
06 Mar

William Blair Initiates Terns Pharmaceuticals at Market Perform

MT Newswires Live
·
28 Feb

Terns Pharmaceuticals Initiated at Market Perform by William Blair

Dow Jones
·
28 Feb

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Terns Pharmaceuticals initiated with a Market Perform at William Blair

TIPRANKS
·
28 Feb

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
27 Feb

JMP Securities Sticks to Its Buy Rating for Terns Pharmaceuticals (TERN)

TIPRANKS
·
26 Feb

BRIEF-Terns Pharmaceuticals Cash & Cash Equivalents Expected To Provide Runway Into 2028

Reuters
·
25 Feb

Terns Pharmaceuticals: Cash & Cash Equivalents Expected to Provide Runway Into 2028

THOMSON REUTERS
·
25 Feb

Terns Pharmaceuticals: on Track to Initiate Tern-601 Phase 2 Falcon Study in Early 2Q25 With 12-Week Data Expected 2H25

THOMSON REUTERS
·
25 Feb

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

GlobeNewswire
·
25 Feb

Terns Pharmaceuticals Appoints Andrew Gengos as CFO

TIPRANKS
·
25 Feb

Terns Pharmaceuticals appoints Andrew Gengos as CFO

TIPRANKS
·
25 Feb

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

THOMSON REUTERS
·
25 Feb

Press Release: Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Dow Jones
·
25 Feb